US Patent Issued on Aug. 5 for "Use of ligustrazine nitrone derivatives in treatment and prevention of diabetic complication diseases" (Chinese Inventors)

ALEXANDRIA, Va., Aug. 6 -- United States Patent no. 12,377,095, issued on Aug. 5.

"Use of ligustrazine nitrone derivatives in treatment and prevention of diabetic complication diseases" was invented by Yuqiang Wang (Qingdao, China), Yewei Sun (Qingdao, China), Lipeng Xu (Qingdao, China), Mei Jing (Qingdao, China), Zaijun Zhang (Qingdao, China), Gaoxiao Zhang (Qingdao, China), Pei Yu (Qingdao, China) and Peng Yi (Qingdao, China).

According to the abstract* released by the U.S. Patent & Trademark Office: "The present invention relates to the use of ligustrazine nitrone derivatives and pharmaceutical composition thereof for the treatment and prevention of diseases of diabetic complications, which include renal anemia. The ligustrazine nitron...